𝔖 Bobbio Scriptorium
✦   LIBER   ✦

αB-crystallin as a marker of lymph node involvement in breast carcinoma

✍ Scribed by Dina Chelouche-Lev; Harriet M. Kluger; Aaron J. Berger; David L. Rimm; Janet E. Price

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
199 KB
Volume
100
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND

It was found previously that αB‐crystallin, a small heat‐shock protein, was overexpressed in a metastatic variant of the GI101A human breast carcinoma cell line. The objective of the current study was to determine whether the expression of αB‐crystallin in primary breast carcinomas was associated with lymph node metastasis and survival.

METHODS

Expression of αB‐crystallin was measured in human breast carcinoma cell lines by immunoblotting. Expression in human breast carcinomas was evaluated by immunohistochemical staining of tissue microarrays that contained samples from 317 patients with lymph node–negative breast carcinoma and 291 patients with lymph node–positive breast carcinoma.

RESULTS

It was found that αB‐crystallin was expressed constitutively in certain breast carcinoma cell lines, including those that were capable of metastasizing in immunodeficient mice. Expression of αB‐crystallin in human tissue samples was associated strongly with lymph node involvement (P < 0.0001; chi‐square test) and, to a lesser degree, with high nuclear grade (P = 0.05). Increased intensity of expression was correlated with shorter survival (P = 0.0091; log‐rank test). Multivariate analysis indicated that αB‐crystallin expression was not independent of lymph node status as a predictor of survival.

CONCLUSIONS

The data obtained in the current study revealed a strong association between high expression levels of αB‐crystallin in primary breast carcinoma specimens and lymph node involvement. Further studies will be needed to prospectively elucidate the role of this novel tumor marker as a clinical prognostic marker in local and locally advanced breast carcinoma as well as its potential status as a new target for therapy in patients with breast carcinoma. Cancer 2004. © 2004 American Cancer Society.

📜 SIMILAR VOLUMES

Predictive model of axillary lymph node
Predictive model of axillary lymph node involvement in women with small invasive breast carcinoma : Axillary metastases in breast carcinoma
✍ Caroline Martin; Bruno Cutuli; Michel Velten 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

## Abstract ## BACKGROUND Axillary lymph node involvement (ALNI) remains the most accurate predictive factor for recurrence risk and survival in patients with invasive breast carcinoma (IBC) and is an essential element in therapeutic decisions. However, axillary dissection (AD) is responsible for

Prediction of axillary lymph node involv
Prediction of axillary lymph node involvement of women with invasive breast carcinoma : A multivariate analysis
✍ Donald I. Promish 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

The Concept of Tenju-gann, or "Natural-End Cancer" T he concept of Tenju-gann proposed by Kitagawa et al. 1 and dis- cussed in the accompanying editorial by Kennedy 2 deserves broader application than these authors suggest. Although cancer is increasingly an illness of the elderly, there remains a

Prediction of axillary lymph node involv
Prediction of axillary lymph node involvement of women with invasive breast carcinoma : A multivariate analysis
✍ Ivo A. Olivotto; Jeremy S. H. Jackson; Donna Mates; Sandra Andersen; Warren Davi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## BACKGROUND. The increasing use of systemic therapy for women with lymph node negative breast carcinoma and earlier stage of disease at mammographic detection raises questions regarding the need for routine axillary lymph node dissection. Predictive modeling for lymph node involvement may be on